Literature DB >> 31840532

The clinical and public health implications and risks of widening the definition of chronic migraine.

Martina Guglielmetti1,2, Alberto Raggi3, Raffaele Ornello4, Simona Sacco4, Domenico D'Amico5, Matilde Leonardi3, Paolo Martelletti1,6.   

Abstract

BACKGROUND: The definition of chronic migraine has long been debated. Recently, it was suggested to define subjects with at least 8/migraine days as chronic migraine; that is, incorporating so-called high frequency episodic migraine (eight or more migraine days but less than 15 headache days per month).
METHODS: We addressed the possible problems that might arise based on this proposal accounting for clinical, pathophysiological, impact and public health aspects. RESULTS AND
CONCLUSIONS: Defining chronic migraine on the basis of headache frequency alone does not account for clinical and pathophysiological aspects, as well as for the impact of chronic migraine in terms of disability and quality of life. Moreover, it is potentially harmful for patients in terms of allocation of resources. These issues are discussed in the present manuscript, and we support the idea of defining high frequency episodic migraine as an independent entity as a viable path to follow.

Entities:  

Keywords:  Chronic migraine; ICHD-3; chronification; disability; high-frequency episodic migraine

Mesh:

Year:  2019        PMID: 31840532     DOI: 10.1177/0333102419895777

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  1 in total

1.  "Triaging" Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies.

Authors:  Paolo Martelletti
Journal:  Pain Ther       Date:  2020-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.